Katalóg evidencie publikačnej činnosti PU

ID záznamu:	PU.Prešov.2017102810223606
Kategória:	ADC
Autor:	Maggioni P. (0%)
Autor:	Anker S.D. (0%)
Autor:	Dahlström U. (0%)
Autor:	Fillipatos G. (0%)
Autor:	Ponikowski P. (0%)
Autor:	Kmec Ján (0%)
Názov:	Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Zdroj:	European journal of heart failure
Lokácia:	Vol. 15, no. 10 (2013), s. 1173-1184
ISSN:	1388-9842
Ohlas:	[1] 2017. FERNANDEZ-GASSO, L., HERNANDO-ARIZALETA, L., PALOMAR-RODRÍGUEZ, J.A. et al. Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data. In International journal of cardiology, ISSN 0167-5273. 2017, vol. 248, s. 246-251.
Ohlas:	[1] 2017. STÖRK, S., HANDROCK, R., JACOB, J. et al. Epidemiology of heart failure in Germany: a retrospective database study. In Clinical research in cardiology, ISSN 1861-0684. 2017, vol. 106, no. 11, s. 913-922.
Ohlas:	[1] 2017. STÖRK, S., HANDROCK, R., JACOB, J. et al. Treatment of chronic heart failure in Germany: a retrospective database study. In Clinical research in cardiology, ISSN 1861-0684. 2017, vol. 106, no. 11, s. 923-932.
Ohlas:	[1] 2017. YANDRAPALLI, S., ANDRIES, G., BISWAS, M. et al. Profile of sacubitril/valsartan in the treatment of heart failure: Patient selection and perspectives. In Vascular health and risk management, ISSN 1176-6344. 2017, vol. 13, s. 369-382.
Ohlas:	[1] 2017. TAVAZZI, L. A brief overview of cardiac resynchronization therapy and its current use in clinical practice. In European journal of heart failure, ISSN 1388-9842. 2017, vol. 19, no. 10, s. 1280-1283.
Ohlas:	[1] 2017. AMBROSY, A.P., GHEORGHIADE, M. Clinical profiles in acute heart failure: one size fits all or not at all?. In Euroepan journal of heart failure, ISSN 1388-9842. 2017, vol. 19, no. 10, s. 1255-1257.
Ohlas:	[1] 2017. SARTIPY, U., DAHLSTRÖM, U., FU, M. et al. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. In JACC: Heart failure, ISSN 2213-1779. 2017, vol. 5, no. 8, s. 565-574.
Ohlas:	[1] 2017. MINANA, G., BOSCH, M.J., NUNEZ, E. et al. Length of stay and risk of very early readmission in acute heart failure. In European journal of internal medicine, ISSN 0953-6205. 2017, vol. 42, s. 61-66.
Ohlas:	[1] 2024. MATACCHIONE, G., PIACENZA, F., PIMPINI, L. et al. The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging. In Clinical epigenetics, ISSN 1868-7075. 2024, roč. 16, č. 1, art no. 175. WOS:001366851100004; SCOPUS.
Ohlas:	[1] 2024. GORGANI, F., NADERIAN, M., KHATIBZADEH, S. et al. Healthcare performance for patients with heart failure in Iran: addressing the tip of the iceberg. In BMC health services research [online], ISSN 1472-6963. 2024 [cit. 2025-04-02], roč. 24, č. 1, art no. 1317. WOS:001346064500004; SCOPUS. Dostupný na internete <https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-024-11699-1>
Ohlas:	[1] 2023. BHATTACHARJEE, P., KHAN, Z. Sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction focusing on the impact on the quality of life: a systematic review and meta-analysis of randomized clinical trials. In Cureus : journal of medical science [online], ISSN 2168-8184. 2023 [cit. 2025-04-02], roč. 15, č. 11, art no. e48674. WOS:001106501800009. Dostupný na internete <https://www.cureus.com/articles/178171-sacubitrilvalsartan-in-the-treatment-of-heart-failure-with-reduced-ejection-fraction-focusing-on-the-impact-on-the-quality-of-life-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials#!/>
Ohlas:	[1] 2024. MAYER JR., O., BRUTHANS, J., JIRÁK, J. et al. The long-term impact of increased red blood cell distribution width detected during hospitalization for heart failure. In Biomarkers in medicine, ISSN 1752-0363. 2024, roč. 18, č. 19, s. 831-842. WOS:001309814800001; SCOPUS.
Ohlas:	[1] 2024. BURGOS, L.M., BALLARI, F.N., SPACCAVENTO, A. et al. In-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction: 90-day prescription patterns and clinical implications. In Current problems in cardiology, ISSN 0146-2806. 2024, roč. 49, č. 10, art no. 102779. WOS:001292150200001; SCOPUS.
Ohlas:	[1] 2023. SENNI, M., SCIATTI, E., BUSSALINO, E. et al. Practical patient care appraisals with use of new potassium binders in heart failure and chronic kidney diseases. In Journal of cardiovascular medicine, ISSN 1558-2027. 2023, roč. 24, č. 11, s. 781-789. WOS:001077861300001; SCOPUS.
Ohlas:	[1] 2023. KOCABAS, U., ERGIN, I., KIVRAK, T. et al. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. In ESC heart failure [online], ISSN 2055-5822. 2023 [cit. 2025-04-02], roč. 10, č. 6, s. 3677-3689. WOS:001082104400001; SCOPUS. Dostupný na internete <https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14559>
Oblasť výskumu:	180